Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 37c/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.60 --0%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
